Felodipine Event Reduction Study

NACompletedINTERVENTIONAL
Enrollment

9,800

Participants

Timeline

Start Date

April 30, 1998

Primary Completion Date

June 30, 2004

Study Completion Date

June 30, 2004

Conditions
Hypertension
Interventions
DRUG

Felodipine

DRUG

Placebo

Trial Locations (1)

100037

Fu Wai Hospital, Beijing

All Listed Sponsors
collaborator

Shanxi Kangbao Pharmaceutical company

UNKNOWN

collaborator

Beijing Hypertension League Insititute

UNKNOWN

lead

Chinese Academy of Medical Sciences

OTHER

NCT01136863 - Felodipine Event Reduction Study | Biotech Hunter | Biotech Hunter